4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001415889-24-021724
CEO sold 31,747 shares at $15.28 ($485,094)
- CEO acquired 62,115 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DAVIS STEPHEN CEO | 2024-08-16 | Grant or award | +17,333 | 173,520 | D | ||
| DAVIS STEPHEN CEO | 2024-08-16 | Grant or award | +44,782 | 218,302 | D | ||
| DAVIS STEPHEN CEO | 2024-08-19 | Sale | −31,747 | $15.28 | $485,094 | 186,555 | D |
| Open-market sales · 31,747 sh · avg $15.28 · $485,094 | |||||||
Loading xslF345X05/form4-08202024_100838.xml…